A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects
NCT03989544
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
315
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
Tezepelumab
Sponsor
AstraZeneca
Collaborators
[object Object]